Injection of corticoids for the treatment of sprains of the fingers.

Phase 1

• Conditions: Acute sprain of the proximal interphalangeal joints of the fingers; Therapeutic area: Diseases [C] - Injuries, poisonings, and occupational diseases [C21]

• Registration Number: EUCTR2016-003875-22-BE
• Lead Sponsor: Centre Hospitalier Universitaire Brugmann

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-11-09
• Last Update Posted: 1 February 2020

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Not specified
• Target Recruitment: 60

Inclusion Criteria

- Adults over 18 years old
- Type I and II and III of the Eaton classification (except if fracture/luxation with more than 50% of the articular surface injured)
- Trauma of one articulation only
- consultation within 2 weeks of trauma
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 53
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 7

Exclusion Criteria

- Patients under 18 years old and over 80 years old
- Pregnant/nursing women
- Eaton classification Type II with a fracture affecting more than 50% of the articular surface, or persistant instability after reduction.
- Open wounds, nerve lesion with sensitive issue and any wound needing a surgical intervention
- Underlying pathologies: rhumatological, neurological, congenital (giving hyperextensive articulations as a result)
- corticoids allergy
- infection within the treated zone
- trauma antecedents at the level of the tendons.

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified